Search Results - "Respiratory syncytial virus"

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan by Akiko Mizukami, Victor Preckler, Frederik Verelst, Taizo Matsuki, Yufan Ho, Daisuke Kurai, Daniel Molnar

Connect to this object online.

Resurgence of influenza and respiratory syncytial virus in Egypt following two years of decline during the COVID-19 pandemic: outpatient clinic survey of infants and children, October 2022 by Amr Kandeel, Manal Fahim, Ola Deghedy, Wael H. Roshdy, Mohamed K. Khalifa, Rabeh El Shesheny, Ahmed Kandeil, Amel Naguib, Salma Afifi, Amira Mohsen, Khaled Abdelghaffar

Connect to this object online.

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis by Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi

Connect to this object online.

Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge by Shuren Zhang, Gan Zhao, Caixia Su, Chaofan Li, Xian Zhou, Weidong Zhao, Yiwei Zhong, Zhonghuai He, Haichang Peng, Aihua Dong, Bin Wang

Connect to this object online.

Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants by Ravasio Roberto, Chirico Gaetano, Sbarigia Urbano

Connect to this object online.

Zedoary turmeric oil injection ameliorates lung inflammation via platelet factor 4 and regulates gut microbiota disorder in respiratory syncytial virus-infected young mice by Yu-Zhuo Wu, Qian Zhang, Hua Li, Cheng-Xi Jiang, Xiao-Kun Li, Hong-Cai Shang, Sheng Lin

Connect to this object online.

The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study by José Francisco Barbas Del Buey, José Francisco Barbas Del Buey, Jesús Íñigo Martínez, María Ángeles Gutiérrez Rodríguez, Marcos Alonso García, Amaya Sánchez-Gómez, María Dolores Lasheras Carbajo, Susana Jiménez Bueno, María Dolores Esteban Vasallo, María Alejandra López Zambrano, Cristina Calvo Rey, Cristina Calvo Rey, Cristina Calvo Rey, Manuel Sanchez Luna, Manuel Sanchez Luna, Marta Molina Olivas, María Araceli Arce Arnáez

Connect to this object online.

Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity by Katherine Schultheis, Holly M Pugh, Janet Oh, Jacklyn Nguyen, Bryan Yung, Charles Reed, Neil Cooch, Jing Chen, Jian Yan, Kar Muthumani, Laurent M. Humeau, David B. Weiner, Kate E. Broderick, Trevor R. F. Smith

Connect to this object online.

Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation via NF-κB Pathway in Mice by Cunsi Shen, Zhengguang Zhang, Tong Xie, Jianjian Ji, Jianya Xu, Lili Lin, Jing Yan, An Kang, Qigang Dai, Yingmei Dong, Jinjun Shan, Shouchuan Wang, Xia Zhao

Connect to this object online.

The mechanism and pharmacodynamics of 2-((1H-indol-3-yl)thio/sulfinyl)-N-pheny acetamide derivative as a novel inhibitor against human respiratory syncytial virus by Ningning Cheng, Nan Jiang, Yuanhui Fu, Zhuxin Xu, Xianglei Peng, Jiemei Yu, Shan Cen, Yucheng Wang, Guoning Zhang, Yanpeng Zheng, Jinsheng He

Connect to this object online.

Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study by Max Beugeling, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink, Wouter L. J. Hinrichs

Connect to this object online.

Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials by Juan Ma, Juan Ma, Juan Ma, Juan Ma, Long Chen, ShiFang Tang, Yuan Shi, Yuan Shi, Yuan Shi

Connect to this object online.

Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus-tackling the burden of disease and implementing preventive solutions by Roberto Debbag, María L. Ávila-Agüero, María L. Ávila-Agüero, José Brea, Helena Brenes-Chacon, Manuel Colomé, Rodrigo de Antonio, Alejandro Díaz-Díaz, Luiza Helena Falleiros-Arlant, Gerardo Fernández, Angela Gentile, Iván Felipe Gutiérrez, Daniel Jarovsky, María del Valle Juárez, Eduardo López-Medina, Abiel Mascareñas, Sebastián Ospina-Henao, Marco A. Safadi, Xavier Sáez-Llorens, Alejandra Soriano-Fallas, Juan P. Torres, Carlos N. Torres-Martínez, Claudia Beltrán-Arroyave

Connect to this object online.

Epidemiological Characteristics of Respiratory Syncytial Virus Infection Among Hospitalized Children With Acute Respiratory Tract Infections From 2014 to 2022 in a Hospital in Hubei Province, China: Longitudinal Surveillance Study by Xing-Wen Hu, Yiguo Zhou, Song Yi, Wan-Xue Zhang, Xin-Rui Wang, Juan Du, Qing-Bin Lu

Connect to this object online.

Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trialResearch in context by Masaaki Mori, Kanako Yoshizaki, Shinichi Watabe, Mika Ishige, Akinari Hinoki, Takuya Kondo, Tomoaki Taguchi, Hisaya Hasegawa, Tomoko Hatata, Naoyuki Tanuma, Kosuke Kirino, Akihiro Hirakawa, Takuya Naruto, Minoru Imai, Ryuji Koike, Kenichiro Hosoi, Satoshi Kusuda

Connect to this object online.

Concentrações de interleucina-2 na secreção nasofaríngea de crianças com bronquiolite viral aguda pelo vírus respiratório sincicial Concentrations of interleukin-2 in the nasopharyngeal secretion of children with acute respiratory syncytial virus bronchiolitis by Katia M. Giugno, Denise C. Machado, Sérgio L. Amantéa, Sérgio S. Menna Barreto

Connect to this object online.

SARS-CoV-2 co-detection with influenza and human respiratory syncytial virus in Ethiopia: Findings from the severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance, January 01, 2021, to June 30, 2022. by Wolde Shure, Adamu Tayachew, Tsegaye Berkessa, Gizaw Teka, Mengistu Biru, Ayele Gebeyehu, Adane Woldeab, Musse Tadesse, Melaku Gonta, Admikew Agune, Aster Hailemariam, Bizuwork Haile, Beza Addis, Muluken Moges, Leuel Lisanwork, Lehageru Gizachew, Eyasu Tigabu, Zelalem Mekuria, Getnet Yimer, Nebiyu Dereje, Jemal Aliy, Sileshi Lulseged, Zenebe Melaku, Ebba Abate, Wondwossen Gebreyes, Mesfin Wossen, Aschalew Abayneh

Connect to this object online.

Diagnosis and Management of Pediatric Diseases by Sergi, Consolato

Subjects: “…respiratory syncytial virus…”
DOAB: download the publication
DOAB: description of the publication

Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation

Subjects: “…respiratory syncytial virus…”
DOAB: download the publication
DOAB: description of the publication

Lipopolysaccharides (LPSs) by Tomás, Juan M.

Subjects: “…respiratory syncytial virus…”
DOAB: download the publication
DOAB: description of the publication